ZyVersa Therapeutics Highlights Data on Kidney Lipotoxicity in Diabetic Kidney Disease

ZyVersa Therapeutics announced data highlighting the critical need for therapies targeting kidney lipotoxicity in diabetic kidney disease (DKD). The ...
Home/KnloSights/Clinical Trial Updates/ZyVersa Therapeutics Highlights Data on Kidney Lipotoxicity in Diabetic Kidney Disease